All News
19906 AI-summarized articles, newest first — page 733 of 830
Natural Gas Prices Decline Amid Mild Weather Trends
Natural gas prices in the U.S. continued to decline due to mild weather conditions. This has impacted trading volumes and overall demand for natural gas. As temperatures remained above seasonal averages, the market saw a decrease in consumption forecasts. Understanding these trends is crucial for investors in energy sectors, particularly related to natural gas companies and futures. The current situation could point to longer-term implications for natural gas asset valuations.
Read More: Natural Gas Prices Decline Amid Mild Weather Trends
Iran President Defends Stance Against U.S. Actions in Letter
Iran's president, Masoud Pezeshkian, released a letter responding to perceived U.S. 'aggression', framing Iran's actions as 'legitimate self-defense'. He criticized the U.S. role in global conflicts and urged Americans to reassess their government's stance on Iran. This public declaration may influence international perceptions and market reactions regarding geopolitical risks in the region. As the situation develops, potential impacts on energy markets could arise from heightened tensions, impacting companies within the sector, though no specific figures were provided.
Read More: Iran President Defends Stance Against U.S. Actions in Letter
Dow (DJIA) Gains 450 Points on Hopes for Quick End to Iran War
On the first trading day of the month, the Dow Jones Industrial Average (DJIA) gained 450 points, attributed to increased optimism regarding a potential resolution to the ongoing conflict in Iran. This sentiment contributed to a broader market increase, with significant upward movements in both the S&P 500 and Nasdaq indices. The trading volume showed robust activity as investors reacted positively to the news. These developments are essential as market participants closely monitor geopolitical events, which can significantly impact market performance.
Read More: Dow (DJIA) Gains 450 Points on Hopes for Quick End to Iran War
S&P 500 Down 5% in March; Analyst Predicts Choppy 2026 Ahead
In March, the S&P 500, Dow Jones, and Nasdaq fell around 5%, concluding a difficult quarter for investors. As of date, the S&P 500 is down approximately 3.5% year-to-date. Analyst Jack Manley from JPMorgan Asset Management suggests that the markets will remain sensitive to both positive and negative news, indicating a potentially volatile 2026. Historical data shows that investors who stay fully invested experience better returns, as significant market gains often occur shortly after downturns, highlighting the risks of timing the market.
Read More: S&P 500 Down 5% in March; Analyst Predicts Choppy 2026 Ahead
Eli Lilly (LLY) Obesity Pill Foundayo Receives FDA Approval
Eli Lilly's (LLY) GLP-1 obesity pill, Foundayo, has received approval from the U.S. FDA. This approval is significant as it paves the way for Eli Lilly to enter the competitive weight loss drug market, where it will face off against rival Novo Nordisk. The successful approval could impact market dynamics and influence trading volumes for both companies. The development is expected to drive Eli Lilly's growth in the pharmaceutical sector and could potentially affect pricing strategies for obesity treatments.
Read More: Eli Lilly (LLY) Obesity Pill Foundayo Receives FDA Approval
Applied Materials (AMAT) and Broadcom (AVGO) on Deutsche Bank's Picks
Deutsche Bank has included Applied Materials (AMAT) and Broadcom (AVGO) in its list of top tech picks. The recommendation comes amidst positive trends in the chip sector, which may lead to continued benefits for AMAT shares. Additionally, AVGO is expected to rebound as revenue from AI-related chips increases. These insights could influence market dynamics in the technology sector, especially for investors focusing on semiconductor stocks.
Read More: Applied Materials (AMAT) and Broadcom (AVGO) on Deutsche Bank's Picks
TSA Agents Paid by Trump; $10 Billion Fund Utilized
TSA agents began receiving pay following an executive order from President Trump due to ongoing delays in Congress regarding funding for the Department of Homeland Security. The compensation is being funded through a section of last year's Republican tax and spending bill, which allocates $10 billion for reimbursing costs related to DHS operations. Trump's actions raise concerns regarding federal spending authority, as they bypass Congressional approval. The funding source remains somewhat unclear, prompting speculation about the administration's choice of fiscal measures. This situation highlights ongoing tensions in federal budget negotiations.
Read More: TSA Agents Paid by Trump; $10 Billion Fund Utilized
Eli Lilly (LLY) wins US approval for Foundayo weight-loss drug
Eli Lilly (LLY) received US approval for its weight-loss drug, Foundayo. This approval introduces competition in the oral obesity drug market, particularly against Novo Nordisk. The specifics of the approval, including safety and efficacy data, have not been disclosed in this article. The entry of Foundayo may influence market dynamics as both companies vie for market share in the oral obesity treatment space.
Read More: Eli Lilly (LLY) wins US approval for Foundayo weight-loss drug
Nike (NKE) Shares Drop Over 14% After Weak Turnaround Guidance
Nike (NKE) reported fiscal third-quarter earnings, revealing a projected sales decline between 2% and 4% for the current quarter, worse than the expected 1.9% growth. The company anticipates a significant 20% drop in China sales, despite FX benefits, affecting overall recovery efforts. Wall Street banks including Goldman Sachs and Bank of America downgraded Nike, citing patience waning due to a lengthy turnaround process. The company's gross margin has declined year-over-year for seven consecutive quarters, with external factors potentially impacting future input costs.
Read More: Nike (NKE) Shares Drop Over 14% After Weak Turnaround Guidance
Eli Lilly (LLY) Receives FDA Approval for Obesity Pill
Eli Lilly (LLY) has received FDA approval for its obesity treatment pill, a significant milestone for the company. This approval may impact Eli Lilly's market position and sales potential in the competitive obesity treatment sector. FDA approvals are critical for pharmaceutical companies as they can lead to increased revenue growth. The approval could bolster investor confidence and influence stock performance in coming sessions.
Read More: Eli Lilly (LLY) Receives FDA Approval for Obesity Pill
Sam's Club (WMT) Raises Membership Fee to $60 Starting May 1
Sam's Club, owned by Walmart (WMT), announced a $10 increase in its annual membership fee, raising it to $60 for basic membership and $120 for Plus members, effective May 1. This change follows a 3.1% growth in net sales to $93 billion last fiscal year and a 23% increase in e-commerce sales during the holiday quarter. The membership increase could potentially add over $200 million in annual income, contributing an estimated two cents to Walmart's annual earnings per share. This adjustment aligns Sam's Club's pricing with BJ's Wholesale Club while remaining below Costco's fees.
Read More: Sam's Club (WMT) Raises Membership Fee to $60 Starting May 1
Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss
Eli Lilly's (LLY) GLP-1 pill, Foundayo, has received FDA approval and will begin shipping via LillyDirect, available in pharmacies
Read More: Eli Lilly (LLY) GLP-1 Pill Approved: Launching Foundayo for Weight Loss
Gas Prices Under $4 Vital for Economic Expansion, Says Jeremy Siegel
Economist Jeremy Siegel stated that the U.S. economy can continue to expand as long as gasoline prices remain below $4 per gallon. This threshold is critical for consumer spending and overall economic health. The statement underscores the impact of fuel prices on economic growth and inflation. Monitoring gas prices may influence market strategies for various sectors.
Read More: Gas Prices Under $4 Vital for Economic Expansion, Says Jeremy Siegel
Vivani Medical (VANI) Price Target Lowered to $3.50 from $4
H.C. Wainwright analyst Yi Chen has lowered Vivani Medical's (VANI) price target to $3.50 from $4, citing an increase in the company's share count as a factor. Despite this reduction, the analyst maintains a Buy rating on the shares. This move follows the recent announcement of the company's 2025 results. The firm believes that NPM-139 may offer efficacy comparable to Wegovy with less frequent administration requirements, which could positively influence market perceptions.
Read More: Vivani Medical (VANI) Price Target Lowered to $3.50 from $4
Wunderbar Faces £500K Tax Hike; Jobs at Risk in Scottish Hospitality
Wunderbar, a bar in Glasgow, reported its business rates would surge from £111,000 to £645,000, prompting potential staff layoffs due to a £500,000 tax increase. Scotland's First Minister announced over £900 million in transitional relief for businesses amid rising living costs and new rateable values for 260,000 properties. The hospitality sector faces significant challenges, with possible job losses in the thousands if trends continue. These developments coincide with rising energy costs and other financial pressures impacting the industry.
Read More: Wunderbar Faces £500K Tax Hike; Jobs at Risk in Scottish Hospitality
Supreme Court hears Trump birthright citizenship case
The U.S. Supreme Court began hearing oral arguments on a birthright citizenship case involving President Donald Trump's executive order. If upheld, this order would prevent tens of thousands of babies born to undocumented immigrants from receiving U.S. citizenship each month. Trump's order also states that from its effective date, babies of illegal immigrants would not be entitled to citizenship documents. This case, known as Trump v. Barbara, marks a significant constitutional challenge regarding citizenship rights in the U.S.
Read More: Supreme Court hears Trump birthright citizenship case
Nvidia (NVDA) Reports 73% Revenue Growth in Fiscal 2026
Nvidia (NVDA) reported a 73% increase in revenue for fiscal 2026, totaling $215.9 billion. The company's guidance indicates $78 billion in revenue for the current quarter, signaling a projected increase of 77% compared to the previous year. Despite the challenges faced by the AI sector, which saw the Global X Artificial Intelligence & Technology ETF decline by nearly 9% this year, the integration of AI continues to drive productivity improvements of 11.5% in various sectors. This suggests sustainable growth potential for key players in AI, including Nvidia and Applied Digital (APLD).
Read More: Nvidia (NVDA) Reports 73% Revenue Growth in Fiscal 2026
Bitcoin (BTC) Down 20% Amid Rising Inflation and U.S. Debt Concerns
Bitcoin (BTC) has declined by 20% over the past year, with concerns about rising inflation due to the Middle East conflict. Robert Kiyosaki continues to advocate for Bitcoin as a superior investment, particularly as he predicts that the upcoming U.S. debt crisis could spur demand for the cryptocurrency. Federal Reserve Chair Jerome Powell emphasized the issue, stating that federal government debt is growing faster than the economy, which is unsustainable. Kiyosaki believes that the mining of the 21 millionth Bitcoin will enhance its value compared to gold, making it an appealing investment in the current economic climate.
Read More: Bitcoin (BTC) Down 20% Amid Rising Inflation and U.S. Debt Concerns
Oil Prices Remain Above $100 Amid Conflict De-Escalation Hints
Global oil prices are reportedly holding above $100 per barrel despite mixed signals regarding geopolitical tensions. President Donald Trump and Iranian President Masoud Pezeshkian have both indicated potential resolution of the ongoing conflict, which could influence market stability. Watching these developments is crucial for investors in the energy sector, as oil price fluctuations directly impact profits. Should the de-escalation materialize, it may lead to significant changes in oil supply and demand dynamics.
Read More: Oil Prices Remain Above $100 Amid Conflict De-Escalation Hints
SpaceX (SPACEX) IPO filing targets over $1.75T valuation
SpaceX has confidentially filed for an initial public offering (IPO), potentially valuing the company at over $1.75 trillion. This move could lead to the largest stock market listing on record, surpassing Saudi Aramco's $50 billion IPO in 2019. The recent merger with Musk's xAI valued SpaceX at $1 trillion, highlighting its rapid growth in space and satellite industries. A successful IPO might rejuvenate interest in public listings among other startups as SpaceX is currently the world's most valuable privately held company.
Read More: SpaceX (SPACEX) IPO filing targets over $1.75T valuation
Altria (MO) Q4 Revenues at $5.85B, Nicotine Pouch Sales Rise 11%
Altria (MO) reported Q4 net revenues of $5.85 billion, a 2% decline driven by lower cigarette sales. The company's on! nicotine pouch brand shipped 177.8 million cans in 2025, reflecting an 11% increase and capturing 13.4% of the pouch market. Full-year adjusted diluted earnings reached $5.42 per share, with 2026 guidance set at $5.56 to $5.72. The company's current dividend yield stands at 6.43%, with a history of 56 consecutive annual increases.
Read More: Altria (MO) Q4 Revenues at $5.85B, Nicotine Pouch Sales Rise 11%
Prosperity Bancshares (PB) Reports Q4 Performance Data and Insights
Prosperity Bancshares, Inc. (PB) closed at $67.18 on March 31, 2026, with a market capitalization of $6.90 billion. Over the past month, the stock's return was -2.53%, and it declined by 4.96% over the past 52 weeks. In its fourth-quarter 2025 investor letter, Artisan Mid Cap Value Fund noted it actively added to its position in PB, citing a long-term relationship with the CEO and a focus on expense management and credit quality. The report indicates that mid-cap stocks, including PB, face challenges relative to large-cap stocks, particularly in growth sectors.
Read More: Prosperity Bancshares (PB) Reports Q4 Performance Data and Insights
ADP Reports 62,000 Job Growth for Private Sector in March 2023
Private sector hiring increased by 62,000 in March 2023, exceeding Dow Jones' estimate of 39,000. This figure is only 4,000 lower than February's revised total. Education and health services contributed 58,000 jobs, while construction added 30,000. Conversely, trade, transportation, and utilities saw a loss of 58,000 jobs. Additionally, wage growth held steady at 4.5% for job stayers and increased to 6.6% for job changers.
Read More: ADP Reports 62,000 Job Growth for Private Sector in March 2023
Nvidia (NVDA) Reports Q4 Revenue of $68.13B, Up 73.2% YoY
Nvidia (NVDA) reported Q4 revenue of $68.13 billion, a 73.2% increase year-over-year, with Data Center revenue at $62.31 billion and networking revenue soaring 263% to $10.98 billion. Broadcom (AVGO) announced Q1 FY2026 revenue of $19.31 billion, up 29.5% year-over-year, driven by AI chip revenue of $8.40 billion, increasing 106% year-over-year, and guidance for Q2 AI semiconductor revenue of $10.7 billion. The differing revenue strategies highlight Nvidia's broad GPU supply across major cloud providers and enterprises, in contrast to Broadcom's custom AI accelerators. Both companies are key players in the AI market, reflecting significant growth in the sector.
Read More: Nvidia (NVDA) Reports Q4 Revenue of $68.13B, Up 73.2% YoY